Efficacy of cough suppressants in children

Area of Science:

• Pediatric Pulmonology
• Clinical Pharmacology
• Evidence-Based Medicine

Background:

• Acute cough is a common pediatric symptom, often treated with over-the-counter medications.
• Codeine and dextromethorphan are frequently used antitussives, but their efficacy in children with acute night cough requires robust evidence.

Purpose of the Study:

• To evaluate the efficacy of codeine and dextromethorphan compared to placebo in alleviating acute night cough symptoms in children.
• To determine if codeine or dextromethorphan offer superior symptom relief over placebo for pediatric cough.

Main Methods:

• A randomized, controlled trial involving children aged 18 months to 12 years with acute night cough (duration < 14 days).
• Participants received codeine, dextromethorphan, or placebo at bedtime for three consecutive nights.
• Symptom severity was assessed daily using parent-reported cough and composite symptom scores.

Main Results:

• Mean cough and composite symptom scores decreased across all three groups (codeine, dextromethorphan, placebo) daily.
• No statistically significant differences in symptom reduction were observed between codeine, dextromethorphan, and placebo groups.
• Regression analysis indicated neither codeine nor dextromethorphan was significantly more effective than placebo (p=0.41 and p=0.70, respectively).

Conclusions:

• In the studied doses, codeine and dextromethorphan do not demonstrate superior efficacy to placebo for treating acute night cough in children.
• The severity of cough at the onset of treatment was a significant factor influencing symptom reduction.
• Further research may be needed to identify effective treatments for pediatric acute cough.